The failure of immunotherapy with dinitrochlorobenzene and Rhus extract for recurrent conjunctival squamous papillomas.
A 25-year-old white male is described who presented with recurrent conjunctival squamous papillomata. Despite prior reports of successful dinitrochlorobenzene use for tropical immunotherapy, its failure in our patient, and the first documented attempt to employ Rhus oleoresin (poison ivy/oak) extract for topical conjunctival immunotherapy is reported. The role of topical immunotherapy in treating recurrent conjunctival papillomas is discussed.
D000287:Administration, Topical; D000328:Adult; D003230:Conjunctival Neoplasms / Q000628:therapy*; D004137:Dinitrochlorobenzene / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D009578:Nitrobenzenes / Q000627:therapeutic use*; D010212:Papilloma / Q000628:therapy*; D010936:Plant Extracts / Q000627:therapeutic use; D010947:Plants, Toxic; D012251:Toxicodendron
D004137:Dinitrochlorobenzene; D009578:Nitrobenzenes; D010936:Plant Extracts